Hit-to-Lead studies: the discovery of potent adamantane amide P2X7 receptor antagonists.
A Hit-to-Lead optimisation programme was carried out on the adamantane high throughput screening hit 1 resulting in the discovery of a number of potent P2X(7) antagonists.